MetaCap

Apyx Medical (APYX) vs Lucid Diagnostics (LUCD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Apyx Medical (APYX) has outperformed Lucid Diagnostics (LUCD) over the past year, losing 40.0% versus a loss of 64.7%. Over five years, APYX leads with a -83.4% price change compared with -95.6% for LUCD. Apyx Medical is the larger company by market cap ($101.1 million vs $72.6 million), about 1.4 times the size.

Apyx Medical converts more of its revenue into profit, with a net margin of -21.2% versus -1232.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

APYX-40.00%LUCD-64.67%
+45%-15%-74%
Nov 21, 20251 yearNov 20, 2026
APYX-85.69%LUCD-96.04%
+5%-48%-101%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

APYX versus LUCD key metrics
MetricAPYXLUCD
Share price$2.40$0.3727
Market cap$101.10M$72.57M
1-day change+0.42%-3.52%
YTD return-31.43%-65.81%
1-year return-40.00%-64.67%
5-year return-83.40%-95.58%
EPS (TTM)$-0.19$-0.36
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$52.84M$4.71M
Revenue growth (YoY)+9.86%+8.28%
Net income (latest FY)$-11.21M$-58.01M
Gross margin62.53%-41.73%
Operating margin-12.20%-1054.82%
Net margin-21.22%-1232.68%
52-week high$5.08$1.63
52-week low$2.25$0.303
Distance from 52-week high-52.76%-77.12%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+170.83%+973.25%
Average volume146.81K5.15M
Shares outstanding42.12M194.71M
Employees20582
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • APYX has outperformed LUCD by 24.7 percentage points over the past year.
  • Apyx Medical is more profitable, keeping -21.2 cents of every revenue dollar as net income versus -1232.7 cents for Lucid Diagnostics.

About Apyx Medical

APYX stock →

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM).

Health Care · Medical/Dental Instruments · 205 employees

About Lucid Diagnostics

LUCD stock →

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States.

Health Care · Medical/Dental Instruments · 82 employees

APYX vs LUCD FAQ

Which is bigger, Apyx Medical or Lucid Diagnostics?

Apyx Medical (APYX) is larger, with a market capitalization of $101.10M compared with $72.57M for Lucid Diagnostics (LUCD).

Which stock has performed better over the past year, APYX or LUCD?

APYX returned -40.00% over the past 12 months, compared with -64.67% for LUCD (price return, excluding dividends). Past performance does not predict future results.

Are Apyx Medical and Lucid Diagnostics in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons